Table of Contents Table of Contents
Previous Page  77 / 280 Next Page
Show Menu
Previous Page 77 / 280 Next Page
Page Background

CCC takes advantage of the latest developments in the fields of

robotic, laparoscopic and microscopic surgery, and hosts one of

the world’s foremost schools of robotic surgery.

In 2014 the CCC opened a new ambulatory surgery unit featuring

a hybrid room that combines all the capabilities of an operating

room with a set of high accuracy and definition medical imaging

equipment. The unit is therefore able to offer both surgical and

interventional radiology procedures with 3D intra-operative

imaging. In oncology, the unit’s main areas of activity focus on

minimally invasive surgery of the digestive tract, liver, biliary tract,

pancreas, urology, breast, gynaecology, bronchology, and

percutaneous and endovascular interventional radiology. The unit’s

in-house equipment, technology and expertise are also available

for a variety of non-cancer-related procedures.

In terms of inpatient support, 2015 will see the addition of three

more fully equipped, state-of-the-art operating theatres, an

intensive care unit, and 25 rooms. In keeping with the CCC’s

patient-centred philosophy, each room has been designed with

comfort and wellbeing in mind.


The CCC offers a unique area for applying the most advanced

forms of chemotherapy. Comprising 32 discreet treatment booths,

the chemotherapy unit strives to eliminate as much of the

physical and mental stress from this process as possible. To this

end, the Champalimaud Clinical Centre offers an unrivalled

treatment environment, with patients having the option of

receiving chemotherapy outside in the Zen garden, designed to

promote peace, tranquillity and wellbeing.

Inside the unit, each booth contains a purpose-built chair to

ensure that patients receive treatment in a state of optimal

comfort, with cable television, wireless internet, and tablet

computers all available.

State-of-the-art diagnosis and treatment

The CCC relies on a comprehensive range of the most advanced

diagnostic tools and makes use of cutting-edge radiology, imaging

and diagnostic nuclear medicine support. Likewise, the pathology

unit also works at the vanguard as it strives to both offer high

quality diagnostic support as well as form a crucial interface

between our research and clinical activities.

The CCC’s innovative approach to cancer care is evident

throughout its diagnostic departments. Nuclear medicine, and

its specialised pathways such as positron emission

tomography, represents the state-of-the-art in cancer diagnosis

and radiotherapy planning, and is used as a key tool in the

CCC. Moreover, the use of transponders (combined with GPS)

for nanolocation and treatment allow non-invasive treatments

that greatly reduce any side effects and minimise

hospitalisation needs.

In addition to their diagnostic support, radiology and nuclear

medicine are also utilised as specialised therapeutic solutions.

Our professionals in interventional radiology offer a range of non-

invasive image-guided treatment options, and our highly

experienced clinical teams have the expertise to use

radiopharmaceuticals as treatment tools where relevant.

Throughout the CCC the treatment and diagnosis techniques

and technologies employed are the most advanced available.

Our advanced endoscopy techniques, for example, are a key

tool in the CCC’s Digestive Unit alongside our other clinical

options. Throughout all departments and services our clinical

staff are active in advancing their fields in search of cure for

oncologic disease.

Throughout all of its activities the Champalimaud Foundation

strives to innovate in order to achieve its mission of bringing the

benefits of biomedical science to those most in need.


Director of Business Affairs

Champalimaud Foundation

tel :

+351 210480200

H O R I Z O N 2 0 2 0 P R O J E C T S : P O R TA L




N AT I O N A L F O C U S : P O R T U G A L